Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer

Cancer Research

Volumn 60, Issue 11, 2000, Pages 3088-3095

  Koukourakis, Michael I ^a,e   Giatromanolaki, Alexandra ^b   Thorpe, Philip E ^c   Brekken, Rolf A ^c   Sivridis, Efthimios ^b   Kakolyris, Stelios ^a   Georgoulias, Vassilis ^a   Gatter, Kevin C ^d   Harris, Adrian L ^d  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e Tumour and Angiogenesis Research Group Iraklion   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; NECROSIS; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034214159     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Vincenti, V., Cassano, C., Rocchi, M., and Persico G. Assignment of the vascular endothelial growth factor gene to the human chromosome 6p21.3. Circulation, 93: 1493-1495, 1996.
2. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
3. Ferrara, N., Houck, K., Jakeman, L., and Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev., 13: 18-32, 1992.
4. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A., C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (Lond.), 376: 62-66, 1995.
5. Burke, P. A., Lehmann-Bruinsma, K., and Powell, J., S. Vascular endothelial growth factor causes endothelial proliferation after vascular injury. Biochem. Biophys. Res. Commun., 207: 348-354, 1995.
6. Vaisman, N., Gospodarowicz, D., and Neufeld, G. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem., 265: 19461-19469, 1990.
7. deVries, C., Escobedo, J. A., Ueno, H., Houck, K. A., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
8. Terman, B. I., Vermazen, M. S., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun., 34: 1578-1586, 1992.
9. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., and Stern, D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med., 172: 1535-1545, 1990.
10. Gerber, H. P., Condorelli, F., Park, J., and Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR is up-regulated by hypoxia. J. Biol. Chem., 272: 23659-23667, 1997.
11. Liu, W., and Ellis, M. Regulation of vascular endothelial growth factor receptor KDR in vitro by a soluble factor in confluent endothelial cells. Pathobiology, 66: 247-252, 1998.
12. Shen, B. Q., Lee, D. Y., Gerber, H. P., Keyr, B. A., Ferrara, N., and Zioncheck, T. F. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem., 273: 29979-29985, 1998.
13. Barleon, B., Siemeister, G., Martiny-Baron, G., Weindel, K., Herzog, C., and Marmfeacute, D. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase (FLT-1 ) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res., 57: 5421-5425, 1997.
14. Ke-Lin, Qu-Hong, Nagy, J. A., Eckelhoefer, I. A., Masse, E. M., Dvorak, A. M., and Dvorak, H. F. Vascular targeting of solid and ascites tumors with antibodies to vascular endothelial growth factor. Eur. J. Cancer, 32A: 2467-2473, 1996.
15. Brekken, R. A., Huang, X., King, S. W., and Thorpe, P. E. Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res., 58: 1952-1959, 1998.
16. Giatromanolaki, A., Koukourakis, M. I., Kakolyris, S., Turley, H., O'Byrne, K., Scott, P. A. E., Pezzella, F., Georgoulias, V., Harris, A. L., and Gatter, K. C. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Clin. Cancer Res., 4: 3017-3024, 1998.
17. Parums, D. V., Cordell, J. L., Micklem, K., Heryet, A. R., Gatter, K. C., and Mason, D. Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol., 43: 752-757, 1990.
18. Giatromanolaki, A., Koukourakis, M., Theodossiou, D., Barbatis, C., Harris, A. L., and Gatter, K. C. Comparative evaluation of angiogenesis assessment with anti-Factor VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin. Cancer Res., 3: 2485-2492, 1997.
19. Guidi, A. J., Abu-jawdeh, G., Tognazzi, K., Dvorak, H. F., and Brown, L. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer (Phila.), 78: 454-460, 1996.
20. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A. J., Dvorak, H. F., Senger, D. R., Connolly, J. L., and Schnitt, S. J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol., 26: 86-91, 1995.
21. Warren, R. S., Yuan, H., Matli, M. R., Gillet, N. A., and Ferrara, N. J. Regulation of vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Investig., 95: 1789-1797, 1995.
22. Abu-Jawdeh, G. M., Faix, J. D., Niloff, J., Tognazzi, K., Manseau, E., Dvorak, H. F., and Brown, L. F. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab. Investig., 74: 1105-1115, 1996.
23. Fox, S. B., Gatter, K. C., Bicknell, R., Going, J. J., Stanton, P., Cooke, T. G., and Harris, A. L. Relationship of endothelial cell proliferation to tumour vascularity in human breast cancer. Cancer Res., 53: 4161-4163, 1993.
24. Berse, B., Hunt, J. A., Diegel, R. J., Morganelli, P., Yeo, K., Brown, F., and Fava, R. A. Hypoxia augments cytokine (transforming growth factor-β(TGF-β) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin. Exp. Immunol., 115: 176-182, 1999.
25. Levine, A. C., Liu, X. H., Greenberg, P. D., Eliashvili, M., Schiff, I. D., Aaronson, S. A., Holland, J. F., and Kirschenbaum, A. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology, 139: 4672-4678, 1998.
26. Jackson, J. R., Minton, J. A., Ho, M. L., Wei, N., and Winkler, J. D. J. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. Rheumatology, 24: 1253-1259, 1997.
27. Speirs, V., and Atkin, S. L. Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumour. Br. J. Cancer, 80: 898-890, 1999.
28. Liu, B., Earl, H. M., Baban, D., Shoaibi, M., Fabra, A., Kerr, D. J., and Seymour, L. W. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem. Biophys. Res. Commun., 217: 721-727, 1995.
29. Gerber, H. P., McMurtrey, A., Kowalski, J., Van, M., Keyt, B. A., Dixit, V., and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol-3-kinase/Akt signal transduction pathway. Requirement for Flk-2/KDR activation. J. Biol. Chem., 273: 30336-30343, 1998.
30. Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., and Jain, R. K. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med., 2, 992-997, 1996.
31. Zocchi, M. R., Ferrero, E., Leone, B. E., Rovere, P., Bianchi, E., Toninelli, E., and Pardi, R. CD31/PECAM-1 driven chemokine-independent transmigration of human T-lymphocyles. Eur. J. Immunol., 26: 759-767, 1996.
32. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189: 824-831, 1992.
33. Harpole, D. H., Jr., Richards, W. G., Herndon, J. E., II, and Sugarbaker L. Angiogenesis and molecular biologic substaging in patients with stage 1 non-small cell lung cancer. Ann. Thorac. Surg., 61: 1470-1476, 1996.
34. Fontanini, G., Lucchi, M., Vignati, S., Mussi, A., Ciardiello, F., DeLaurentiis, M., De Placido, S., Basolo, F., Angeletti, C. A., and Bevilacqua, G. Angiogenesis as a prognostic indicator in non-small cell lung carcinoma: a prospective study. J. Natl. Cancer Inst., S9: 881-886, 1997.
35. Jouan, V., Canron, X., Alemany, M., Caen, J. P., Quentin, G., Plouet, J., and Bikfalvi, A. Inhibition of in vitro angiogenesis by platelet faclor-4 derived peptides and mechanism of action. Blood, 94: 984-993, 1999.
36. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thomas, U. A., and Cunel, D. T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. USA, 95: 8795-8800, 1998.
37. D'Angelo, G., Martini, J. F., Iiri, T., Fantl, W. J., Martial, J., and Weiner, R. I. The 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol. Endocrinol., 13: 692-704, 1999.
38. Liu, J., Razani, B., Tang, S., Terman, B. I., Ware, J. A., and Lisanti, M. P. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem., 274: 15781-15785, 1999.
39. Jacquemier, J. D., Penault-LLorca, F. M., Bertucci, F., Sun, Z. Z., Houvenaeghel, G. F., Geneix, J A., Puig, B. D., Bardau, V. I., Hassoun, I. A., Birnbaum, D., and Viens, P. J. Angiogenesis as a prognostic marker in breast carcinomas treated with conventional adjuvant chemotherapy. J. Pathol., 184: 130-135, 1998.
40. Giatromanolaki, A., Koukourakis, M. I., Georgoulias, V., Gatter, K. C., Harris, A. L., Fountzilas G. Angiogenesis vs. response after combined chemo-radiotherapy of squamous cell head and neck cancer. Int. J. Cancer, 80: 810-817, 1999.
41. Cooper, R. A., Wilks, D. P., Logue, J. P., Davidson, S. E., Hunter, R. D., Roberts, S. A., and West, C. M. L. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin. Cancer Res., 4: 2795-2800, 1998.